A new trading day began on Friday, with Neuronetics Inc (NASDAQ: STIM) stock price up 7.19% from the previous day of trading, before settling in for the closing price of $1.39. STIM’s price has ranged from $0.92 to $5.92 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 2.71% over the past five years. Meanwhile, its annual earnings per share averaged 56.57%. With a float of $37.25 million, this company’s outstanding shares have now reached $68.44 million.
Neuronetics Inc (STIM) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Neuronetics Inc is 38.94%, while institutional ownership is 31.14%. The most recent insider transaction that took place on Aug 08 ’25, was worth 13,020,000. In this transaction 10% Owner of this company sold 3,500,000 shares at a rate of $3.72, taking the stock ownership to the 1,142,351 shares. Before that another transaction happened on Aug 08 ’25, when Company’s 10% Owner proposed sale 2,925,554 for $3.72, making the entire transaction worth $10,883,061.
Neuronetics Inc (STIM) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.04 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 56.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.99% during the next five years compared to 2.71% growth over the previous five years of trading.
Neuronetics Inc (NASDAQ: STIM) Trading Performance Indicators
Here are Neuronetics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of Neuronetics Inc (STIM)
Neuronetics Inc (NASDAQ: STIM) saw its 5-day average volume 1.16 million, a negative change from its year-to-date volume of 1.35 million. As of the previous 9 days, the stock’s Stochastic %D was 22.07%.
During the past 100 days, Neuronetics Inc’s (STIM) raw stochastic average was set at 6.67%, which indicates a significant decrease from 21.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1966 in the past 14 days, which was lower than the 0.2585 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.4881, while its 200-day Moving Average is $3.5987. Nevertheless, the first resistance level for the watch stands at $1.5450 in the near term. At $1.6000, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.6700. If the price goes on to break the first support level at $1.4200, it is likely to go to the next support level at $1.3500. The third support level lies at $1.2950 if the price breaches the second support level.
Neuronetics Inc (NASDAQ: STIM) Key Stats
With a market capitalization of 102.04 million, the company has a total of 68,486K Shares Outstanding. Currently, annual sales are 74,890 K while annual income is -43,710 K. The company’s previous quarter sales were 37,300 K while its latest quarter income was -9,050 K.
